Please assess the completion status of the following clinical trial:

Trial Title: NICU-TECH RM9L-RS Probe ME Feasibility Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Neonates that are 23 gestational weeks at birth (and greater than 500 grams) to a 6 month old born infant at term (maximum weight 7 kg) who already have one or more lines placed (PIV/PAC/UVC/UACs/PICC) as part of their medical care. NO INFANT WILL HAVE A LINE PLACE FOR THE PURPOSE OF THIS STUDY~Exclusion Criteria:~* Neonates that are less than 23 gestational weeks at birth~* Neonates that are 23 gestational weeks at birth but are less than 500 grams in weight~* Patients weighing more than 7 kg.-Patients older than 6 months

- Gender: ALL
- Minimum Age: 23 Weeks
- Maximum Age: 6 Months
- Healthy Volunteers: f

Study Arms:
- Arm 1: observational ultrasound (Type: None): Collection of image data with the ultrasound probe.

Based on this trial design, predict the completion outcome and termination type (if applicable).